How to train glioma cells to die: molecular challenges in cell death
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
How to train glioma cells to die: molecular challenges in cell death
Authors
Keywords
Glioma, Apoptosis, Autophagy, Necrosis, Resistance
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume 126, Issue 3, Pages 377-384
Publisher
Springer Nature
Online
2015-11-05
DOI
10.1007/s11060-015-1980-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bevacizumab in high-grade gliomas: past, present, and future
- (2015) Richard C Curry et al. Expert Review of Anticancer Therapy
- A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme
- (2014) Myrna R Rosenfeld et al. Autophagy
- ABCB1, ABCG2, and PTEN Determine the Response of Glioblastoma to Temozolomide and ABT-888 Therapy
- (2014) F. Lin et al. CLINICAL CANCER RESEARCH
- NEO212, Temozolomide Conjugated to Perillyl Alcohol, Is a Novel Drug for Effective Treatment of a Broad Range of Temozolomide-Resistant Gliomas
- (2014) H.-Y. Cho et al. MOLECULAR CANCER THERAPEUTICS
- VAMP8 facilitates cellular proliferation and temozolomide resistance in human glioma cells
- (2014) Yuanyuan Chen et al. NEURO-ONCOLOGY
- Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy
- (2014) Encouse B. Golden et al. Neurosurgical Focus
- Bevacizumab for Newly Diagnosed Glioblastoma
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Pregabalin versus Pramipexole for Restless Legs Syndrome
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Autophagy inhibition induces enhanced proapoptotic effects of ZD6474 in glioblastoma
- (2013) J Shen et al. BRITISH JOURNAL OF CANCER
- An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma
- (2013) David A Reardon et al. Expert Review of Vaccines
- Suppression of Autophagy Enhanced Growth Inhibition and Apoptosis of Interferon-β in Human Glioma Cells
- (2013) Yubin Li et al. MOLECULAR NEUROBIOLOGY
- Thymoquinone Inhibits Autophagy and Induces Cathepsin-Mediated, Caspase-Independent Cell Death in Glioblastoma Cells
- (2013) Ira O. Racoma et al. PLoS One
- Evaluation of poly (ADP-ribose) polymerase inhibitor ABT-888 combined with radiotherapy and temozolomide in glioblastoma
- (2013) Lara Barazzuol et al. Radiation Oncology
- Hypoxia-Induced Autophagy Promotes Tumor Cell Survival and Adaptation to Antiangiogenic Treatment in Glioblastoma
- (2012) Y.-L. Hu et al. CANCER RESEARCH
- Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis
- (2012) L. Ouyang et al. CELL PROLIFERATION
- NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality
- (2012) Roger Stupp et al. EUROPEAN JOURNAL OF CANCER
- Autophagy and cancer - issues we need to digest
- (2012) E. Y. Liu et al. JOURNAL OF CELL SCIENCE
- Smac mimetic sensitizes glioblastoma cells to Temozolomide-induced apoptosis in a RIP1- and NF-κB-dependent manner
- (2012) L Wagner et al. ONCOGENE
- Role of autophagy in histone deacetylase inhibitor-induced apoptotic and nonapoptotic cell death
- (2012) N. Gammoh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prognostic impact of the expression/phosphorylation of the BH3-only proteins of the BCL-2 family in glioblastoma multiforme
- (2012) P F Cartron et al. Cell Death & Disease
- What drives intense apoptosis resistance and propensity for necrosis in glioblastoma? A role for Bcl2L12 as a multifunctional cell death regulator
- (2011) Alexander H. Stegh et al. CELL CYCLE
- EGFR and EGFRvIII interact with PUMA to inhibit mitochondrial translocalization of PUMA and PUMA-mediated apoptosis independent of EGFR kinase activity
- (2010) Hu Zhu et al. CANCER LETTERS
- Glioma oncoprotein Bcl2L12 inhibits the p53 tumor suppressor
- (2010) A. H. Stegh et al. GENES & DEVELOPMENT
- Necroptosis: A novel therapeutic target for glioblastoma
- (2010) Yu-Gang Jiang et al. MEDICAL HYPOTHESES
- The BCL-2 Family Reunion
- (2010) Jerry E. Chipuk et al. MOLECULAR CELL
- Mitochondria and cell death: outer membrane permeabilization and beyond
- (2010) Stephen W. G. Tait et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Inhibition of autophagy induced by proteasome inhibition increases cell death in human SHG-44 glioma cells
- (2009) Peng-fei Ge et al. ACTA PHARMACOLOGICA SINICA
- The Double-Edged Sword of Autophagy Modulation in Cancer
- (2009) E. White et al. CLINICAL CANCER RESEARCH
- Lysosomes as “Suicide Bags” in Cell Death: Myth or Reality?
- (2009) Boris Turk et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
- (2009) Michael Weller et al. Nature Reviews Neurology
- Autophagy in the Pathogenesis of Disease
- (2008) Beth Levine et al. CELL
- Resistance of human glioblastoma multiforme cells to growth factor inhibitors is overcome by blockade of inhibitor of apoptosis proteins
- (2008) David S. Ziegler et al. JOURNAL OF CLINICAL INVESTIGATION
- Delta-24-RGD in Combination With RAD001 Induces Enhanced Anti-glioma Effect via Autophagic Cell Death
- (2008) Marta M Alonso et al. MOLECULAR THERAPY
- Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins
- (2008) K E Tagscherer et al. ONCOGENE
- Lysosomal membrane permeabilization in cell death
- (2008) P Boya et al. ONCOGENE
- Bcl2L12-mediated inhibition of effector caspase-3 and caspase-7 via distinct mechanisms in glioblastoma
- (2008) A. H. Stegh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now